Breaking News

WuXi PharmaTech Invests in TruTag Technologies

April 8, 2014

To explore collaborations for on-dose authentication solution

WuXi PharmaTech (Cayman) Inc. has made an investment in TruTag Technologies, Inc., a developer of the edible, covert security platform designed to address product counterfeiting. WuXi and TruTag will also explore collaborations to offer WuXi’s customers the TruTag on-dose authentication solution to help prevent counterfeiting and enhance drug safety.
TruTag microtags (TruTags) are inert and edible and can be integrated into a product without packaging or labels. According to the company, the technology has millions of optical patterns that can be embedded into a TruTag, a dust-sized particle smaller than the width of a human hair. This technology allows pharmaceutical companies to be able to field-read finished tablets circulating in the wholesale and retail market to determine the authenticity and origin of medicines, including site and date of manufacture, lots, and other critical data.
"TruTag is very excited to work with WuXi to explore the development of our on-dose authentication solution for WuXi’s pharmaceutical customers,” said Dr. Hank C.K. Wuh, chairman of TruTag Technologies. “This innovative technology is an important new weapon in fighting the growing global problem of counterfeit drugs.”
"WuXi is pleased to invest in this cutting-edge technology and to explore its further development to enhance patient safety and protect our customers’ intellectual property,” said Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech. 

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks